# STERIS plc (STE)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $20.54B  
**Price:** $208.10 (-2.25%)

> STERIS plc is a leading provider of infection prevention and other surgical products and services in the healthcare sector. The company develops, manufactures, and distributes a comprehensive range of sterile processing equipment, consumables, and services designed to help healthcare facilities maintain sterility and safety standards. Its offerings include sterilization systems, washing and decontamination equipment, surgical tables, lights, and endoscopes, along with maintenance and support services. STERIS plc serves hospitals, ambulatory surgery centers, and pharmaceutical manufacturers through its core segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. These segments enable the delivery of critical solutions for reprocessing medical devices, sterilizing single-use medical products, and supporting biopharmaceutical production. Founded in 1985 and headquartered in Dublin, Ireland, STERIS plc plays a vital role in enhancing patient safety and operational efficiency across global healthcare and life sciences markets.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $5.94B | $2.63B | $1.10B | $782M | $7.93 |
| 2025 | $5.46B | $2.40B | $867M | $615M | $6.20 |
| 2024 | $5.14B | $2.22B | $836M | $378M | $3.81 |
| 2023 | $4.54B | $1.98B | $791M | $107M | $1.07 |
| 2022 | $4.22B | $1.88B | $478M | $244M | $2.48 |
| 2021 | $3.11B | $1.34B | $548M | $397M | $4.63 |
| 2020 | $3.03B | $1.32B | $537M | $408M | $4.76 |
| 2019 | $2.78B | $1.17B | $411M | $304M | $3.55 |
| 2018 | $2.62B | $1.09B | $400M | $291M | $3.39 |
| 2017 | $2.61B | $1.03B | $226M | $110M | $1.28 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2026 | $10.74B | $3.54B | $7.18B | — | $1.81B |
| 2025 | $10.15B | $3.53B | $6.60B | $172M | $1.92B |
| 2024 | $11.06B | $4.75B | $6.30B | $207M | $3.12B |
| 2023 | $10.82B | $4.73B | $6.08B | $208M | $3.02B |
| 2022 | $11.42B | $4.88B | $6.53B | $348M | $2.95B |
| 2021 | $6.57B | $2.68B | $3.88B | $221M | $1.65B |
| 2020 | $5.44B | $2.02B | $3.41B | $320M | $1.15B |
| 2019 | $5.07B | $1.89B | $3.18B | $221M | $1.18B |
| 2018 | $5.20B | $1.98B | $3.21B | $202M | $1.32B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2026 | $1.34B | $369M | $972M |
| 2025 | $1.15B | $370M | $778M |
| 2024 | $973M | $360M | $613M |
| 2023 | $757M | $362M | $395M |
| 2022 | $685M | $288M | $397M |
| 2021 | $690M | $239M | $450M |
| 2020 | $591M | $215M | $376M |
| 2019 | $540M | $190M | $350M |
| 2018 | $458M | $165M | $292M |
| 2017 | $424M | $173M | $251M |

Source: [CompaniesByCap](https://companiesbycap.com/company/STE)